JP2022034075A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022034075A5 JP2022034075A5 JP2021215385A JP2021215385A JP2022034075A5 JP 2022034075 A5 JP2022034075 A5 JP 2022034075A5 JP 2021215385 A JP2021215385 A JP 2021215385A JP 2021215385 A JP2021215385 A JP 2021215385A JP 2022034075 A5 JP2022034075 A5 JP 2022034075A5
- Authority
- JP
- Japan
- Prior art keywords
- growth factor
- protein
- soluble polymer
- factor
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004169 proteins and genes Human genes 0.000 claims 54
- 108090000623 proteins and genes Proteins 0.000 claims 54
- 238000000034 method Methods 0.000 claims 47
- 229920003169 water-soluble polymer Polymers 0.000 claims 35
- 230000001225 therapeutic effect Effects 0.000 claims 31
- 239000003102 growth factor Substances 0.000 claims 26
- JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical compound CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 claims 20
- 210000000988 bone and bone Anatomy 0.000 claims 18
- 125000002344 aminooxy group Chemical group [H]N([H])O[*] 0.000 claims 16
- 230000000921 morphogenic effect Effects 0.000 claims 16
- 239000007800 oxidant agent Substances 0.000 claims 11
- 102000005962 receptors Human genes 0.000 claims 11
- 108020003175 receptors Proteins 0.000 claims 11
- 125000000837 carbohydrate group Chemical group 0.000 claims 10
- 230000001590 oxidative effect Effects 0.000 claims 10
- 238000003756 stirring Methods 0.000 claims 10
- 238000004587 chromatography analysis Methods 0.000 claims 8
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical group [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims 8
- 150000002923 oximes Chemical class 0.000 claims 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 6
- 238000006243 chemical reaction Methods 0.000 claims 6
- 238000000502 dialysis Methods 0.000 claims 6
- 238000001914 filtration Methods 0.000 claims 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- 108010054218 Factor VIII Proteins 0.000 claims 5
- 102000001690 Factor VIII Human genes 0.000 claims 5
- 241000872931 Myoporum sandwicense Species 0.000 claims 5
- 230000015572 biosynthetic process Effects 0.000 claims 5
- 229960000301 factor viii Drugs 0.000 claims 5
- 229920001184 polypeptide Polymers 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- -1 tPA Proteins 0.000 claims 5
- 102100022641 Coagulation factor IX Human genes 0.000 claims 4
- 108010076282 Factor IX Proteins 0.000 claims 4
- 108010054265 Factor VIIa Proteins 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 4
- 238000013019 agitation Methods 0.000 claims 4
- 238000010668 complexation reaction Methods 0.000 claims 4
- 229960004222 factor ix Drugs 0.000 claims 4
- 229940012414 factor viia Drugs 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims 4
- 230000012010 growth Effects 0.000 claims 4
- 238000004191 hydrophobic interaction chromatography Methods 0.000 claims 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 4
- 210000000440 neutrophil Anatomy 0.000 claims 4
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims 3
- 102000004127 Cytokines Human genes 0.000 claims 3
- 108090000695 Cytokines Proteins 0.000 claims 3
- 102000009465 Growth Factor Receptors Human genes 0.000 claims 3
- 108010009202 Growth Factor Receptors Proteins 0.000 claims 3
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims 3
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 238000010828 elution Methods 0.000 claims 3
- 238000001556 precipitation Methods 0.000 claims 3
- 238000000108 ultra-filtration Methods 0.000 claims 3
- 238000005406 washing Methods 0.000 claims 3
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 claims 2
- 108010008165 Etanercept Proteins 0.000 claims 2
- 108010014172 Factor V Proteins 0.000 claims 2
- 108010014173 Factor X Proteins 0.000 claims 2
- 108010074864 Factor XI Proteins 0.000 claims 2
- 108010080865 Factor XII Proteins 0.000 claims 2
- 102000000429 Factor XII Human genes 0.000 claims 2
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims 2
- 102000003956 Fibroblast growth factor 8 Human genes 0.000 claims 2
- 108090000368 Fibroblast growth factor 8 Proteins 0.000 claims 2
- 108010024636 Glutathione Proteins 0.000 claims 2
- 102000004877 Insulin Human genes 0.000 claims 2
- 108090001061 Insulin Proteins 0.000 claims 2
- 108010047761 Interferon-alpha Proteins 0.000 claims 2
- 102000006992 Interferon-alpha Human genes 0.000 claims 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 2
- 108090000630 Oncostatin M Proteins 0.000 claims 2
- 102000004140 Oncostatin M Human genes 0.000 claims 2
- 102000003666 Placenta Growth Factor Human genes 0.000 claims 2
- 108010082093 Placenta Growth Factor Proteins 0.000 claims 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 2
- 108010000499 Thromboplastin Proteins 0.000 claims 2
- 102000002262 Thromboplastin Human genes 0.000 claims 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 2
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 2
- 230000003213 activating effect Effects 0.000 claims 2
- 238000005571 anion exchange chromatography Methods 0.000 claims 2
- 230000023555 blood coagulation Effects 0.000 claims 2
- 230000001886 ciliary effect Effects 0.000 claims 2
- 238000004140 cleaning Methods 0.000 claims 2
- 230000000536 complexating effect Effects 0.000 claims 2
- 229930003836 cresol Natural products 0.000 claims 2
- 230000008472 epithelial growth Effects 0.000 claims 2
- 229960003180 glutathione Drugs 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- 238000011534 incubation Methods 0.000 claims 2
- 229940125396 insulin Drugs 0.000 claims 2
- 238000004255 ion exchange chromatography Methods 0.000 claims 2
- ACKFDYCQCBEDNU-UHFFFAOYSA-J lead(2+);tetraacetate Chemical compound [Pb+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O ACKFDYCQCBEDNU-UHFFFAOYSA-J 0.000 claims 2
- 208000032839 leukemia Diseases 0.000 claims 2
- 238000011068 loading method Methods 0.000 claims 2
- 229930182817 methionine Natural products 0.000 claims 2
- 230000000877 morphologic effect Effects 0.000 claims 2
- 230000002956 necrotizing effect Effects 0.000 claims 2
- 210000004498 neuroglial cell Anatomy 0.000 claims 2
- 229910052700 potassium Inorganic materials 0.000 claims 2
- 239000011591 potassium Substances 0.000 claims 2
- 238000000746 purification Methods 0.000 claims 2
- 239000011347 resin Substances 0.000 claims 2
- 229920005989 resin Polymers 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 238000001542 size-exclusion chromatography Methods 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- CSMWJXBSXGUPGY-UHFFFAOYSA-L sodium dithionate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)S([O-])(=O)=O CSMWJXBSXGUPGY-UHFFFAOYSA-L 0.000 claims 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 2
- 229960005356 urokinase Drugs 0.000 claims 2
- 108010047303 von Willebrand Factor Proteins 0.000 claims 2
- 102100036537 von Willebrand factor Human genes 0.000 claims 2
- 229960001134 von willebrand factor Drugs 0.000 claims 2
- 102000043853 ADAMTS13 Human genes 0.000 claims 1
- 108091005670 ADAMTS13 Proteins 0.000 claims 1
- 102000009027 Albumins Human genes 0.000 claims 1
- 108010088751 Albumins Proteins 0.000 claims 1
- 102100022987 Angiogenin Human genes 0.000 claims 1
- 102100034613 Annexin A2 Human genes 0.000 claims 1
- 108090000668 Annexin A2 Proteins 0.000 claims 1
- 108090000669 Annexin A4 Proteins 0.000 claims 1
- 102100034612 Annexin A4 Human genes 0.000 claims 1
- 102100028892 Cardiotrophin-1 Human genes 0.000 claims 1
- 102000014914 Carrier Proteins Human genes 0.000 claims 1
- 108010008951 Chemokine CXCL12 Proteins 0.000 claims 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 claims 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 claims 1
- 108090000056 Complement factor B Proteins 0.000 claims 1
- 102000003712 Complement factor B Human genes 0.000 claims 1
- 102100030323 Epigen Human genes 0.000 claims 1
- 108010016906 Epigen Proteins 0.000 claims 1
- 102400001329 Epiregulin Human genes 0.000 claims 1
- 101800000155 Epiregulin Proteins 0.000 claims 1
- 102000004641 Fetal Proteins Human genes 0.000 claims 1
- 108010003471 Fetal Proteins Proteins 0.000 claims 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims 1
- 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 claims 1
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 claims 1
- 102000004864 Fibroblast growth factor 10 Human genes 0.000 claims 1
- 108090001047 Fibroblast growth factor 10 Proteins 0.000 claims 1
- 102000014252 Fibroblast growth factor 11 Human genes 0.000 claims 1
- 108050003237 Fibroblast growth factor 11 Proteins 0.000 claims 1
- 102000014250 Fibroblast growth factor 12 Human genes 0.000 claims 1
- 108050003239 Fibroblast growth factor 12 Proteins 0.000 claims 1
- 102000012570 Fibroblast growth factor 16 Human genes 0.000 claims 1
- 108050002072 Fibroblast growth factor 16 Proteins 0.000 claims 1
- 102000012565 Fibroblast growth factor 17 Human genes 0.000 claims 1
- 108050002074 Fibroblast growth factor 17 Proteins 0.000 claims 1
- 102100031734 Fibroblast growth factor 19 Human genes 0.000 claims 1
- 101710153349 Fibroblast growth factor 19 Proteins 0.000 claims 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 1
- 102000012558 Fibroblast growth factor 20 Human genes 0.000 claims 1
- 108050002085 Fibroblast growth factor 20 Proteins 0.000 claims 1
- 102000003973 Fibroblast growth factor 21 Human genes 0.000 claims 1
- 108090000376 Fibroblast growth factor 21 Proteins 0.000 claims 1
- 102000003969 Fibroblast growth factor 4 Human genes 0.000 claims 1
- 108090000381 Fibroblast growth factor 4 Proteins 0.000 claims 1
- 102000003967 Fibroblast growth factor 5 Human genes 0.000 claims 1
- 108090000380 Fibroblast growth factor 5 Proteins 0.000 claims 1
- 102000003968 Fibroblast growth factor 6 Human genes 0.000 claims 1
- 108090000382 Fibroblast growth factor 6 Proteins 0.000 claims 1
- 102000003972 Fibroblast growth factor 7 Human genes 0.000 claims 1
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 claims 1
- 102000003957 Fibroblast growth factor 9 Human genes 0.000 claims 1
- 108090000367 Fibroblast growth factor 9 Proteins 0.000 claims 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 claims 1
- 102100025947 Insulin-like growth factor II Human genes 0.000 claims 1
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 claims 1
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 claims 1
- 102100026720 Interferon beta Human genes 0.000 claims 1
- 102100037850 Interferon gamma Human genes 0.000 claims 1
- 108090000467 Interferon-beta Proteins 0.000 claims 1
- 108010074328 Interferon-gamma Proteins 0.000 claims 1
- 108010050904 Interferons Proteins 0.000 claims 1
- 102000014150 Interferons Human genes 0.000 claims 1
- 108090000174 Interleukin-10 Proteins 0.000 claims 1
- 108090000177 Interleukin-11 Proteins 0.000 claims 1
- 108010065805 Interleukin-12 Proteins 0.000 claims 1
- 108090000172 Interleukin-15 Proteins 0.000 claims 1
- 101800003050 Interleukin-16 Proteins 0.000 claims 1
- 102000013691 Interleukin-17 Human genes 0.000 claims 1
- 108050003558 Interleukin-17 Proteins 0.000 claims 1
- 108090000171 Interleukin-18 Proteins 0.000 claims 1
- 108050009288 Interleukin-19 Proteins 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 108010065637 Interleukin-23 Proteins 0.000 claims 1
- 108010002386 Interleukin-3 Proteins 0.000 claims 1
- 101710181613 Interleukin-31 Proteins 0.000 claims 1
- 108010067003 Interleukin-33 Proteins 0.000 claims 1
- 108090000978 Interleukin-4 Proteins 0.000 claims 1
- 108010002616 Interleukin-5 Proteins 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 108010002586 Interleukin-7 Proteins 0.000 claims 1
- 108090001007 Interleukin-8 Proteins 0.000 claims 1
- 108010002335 Interleukin-9 Proteins 0.000 claims 1
- 235000013878 L-cysteine Nutrition 0.000 claims 1
- 239000004201 L-cysteine Substances 0.000 claims 1
- 102000004856 Lectins Human genes 0.000 claims 1
- 108090001090 Lectins Proteins 0.000 claims 1
- 102000016267 Leptin Human genes 0.000 claims 1
- 108010092277 Leptin Proteins 0.000 claims 1
- 102000004895 Lipoproteins Human genes 0.000 claims 1
- 108090001030 Lipoproteins Proteins 0.000 claims 1
- 102000009151 Luteinizing Hormone Human genes 0.000 claims 1
- 108010073521 Luteinizing Hormone Proteins 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 102000004230 Neurotrophin 3 Human genes 0.000 claims 1
- 108090000742 Neurotrophin 3 Proteins 0.000 claims 1
- 102000003683 Neurotrophin-4 Human genes 0.000 claims 1
- 108090000099 Neurotrophin-4 Proteins 0.000 claims 1
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 claims 1
- 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 claims 1
- 102000003946 Prolactin Human genes 0.000 claims 1
- 108010057464 Prolactin Proteins 0.000 claims 1
- 101800004937 Protein C Proteins 0.000 claims 1
- 102000017975 Protein C Human genes 0.000 claims 1
- 229940096437 Protein S Drugs 0.000 claims 1
- 102000029301 Protein S Human genes 0.000 claims 1
- 108010066124 Protein S Proteins 0.000 claims 1
- 101710150593 Protein beta Proteins 0.000 claims 1
- 101710179016 Protein gamma Proteins 0.000 claims 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 claims 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 claims 1
- 101800001700 Saposin-D Proteins 0.000 claims 1
- 229920002684 Sepharose Polymers 0.000 claims 1
- 102000004584 Somatomedin Receptors Human genes 0.000 claims 1
- 108010017622 Somatomedin Receptors Proteins 0.000 claims 1
- 102000013275 Somatomedins Human genes 0.000 claims 1
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims 1
- 102100031372 Thymidine phosphorylase Human genes 0.000 claims 1
- 108700023160 Thymidine phosphorylases Proteins 0.000 claims 1
- 102000011923 Thyrotropin Human genes 0.000 claims 1
- 108010061174 Thyrotropin Proteins 0.000 claims 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims 1
- 102000004357 Transferases Human genes 0.000 claims 1
- 108090000992 Transferases Proteins 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 229960002964 adalimumab Drugs 0.000 claims 1
- 238000001042 affinity chromatography Methods 0.000 claims 1
- 229940050528 albumin Drugs 0.000 claims 1
- 125000003172 aldehyde group Chemical group 0.000 claims 1
- 102000005840 alpha-Galactosidase Human genes 0.000 claims 1
- 108010030291 alpha-Galactosidase Proteins 0.000 claims 1
- 108010072788 angiogenin Proteins 0.000 claims 1
- 239000005667 attractant Substances 0.000 claims 1
- 102000005936 beta-Galactosidase Human genes 0.000 claims 1
- 108010005774 beta-Galactosidase Proteins 0.000 claims 1
- 108091008324 binding proteins Proteins 0.000 claims 1
- 230000004071 biological effect Effects 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 108010041776 cardiotrophin 1 Proteins 0.000 claims 1
- 230000031902 chemoattractant activity Effects 0.000 claims 1
- 229940015047 chorionic gonadotropin Drugs 0.000 claims 1
- 229960001251 denosumab Drugs 0.000 claims 1
- 229940073621 enbrel Drugs 0.000 claims 1
- 229940011871 estrogen Drugs 0.000 claims 1
- 239000000262 estrogen Substances 0.000 claims 1
- 229960000403 etanercept Drugs 0.000 claims 1
- 108060002885 fetuin Proteins 0.000 claims 1
- 102000013361 fetuin Human genes 0.000 claims 1
- 229940126864 fibroblast growth factor Drugs 0.000 claims 1
- 102000003684 fibroblast growth factor 13 Human genes 0.000 claims 1
- 108090000047 fibroblast growth factor 13 Proteins 0.000 claims 1
- 229940098448 fibroblast growth factor 7 Drugs 0.000 claims 1
- 230000003325 follicular Effects 0.000 claims 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims 1
- 235000019410 glycyrrhizin Nutrition 0.000 claims 1
- 229960002897 heparin Drugs 0.000 claims 1
- 229920000669 heparin Polymers 0.000 claims 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940048921 humira Drugs 0.000 claims 1
- 102000028416 insulin-like growth factor binding Human genes 0.000 claims 1
- 108091022911 insulin-like growth factor binding Proteins 0.000 claims 1
- 229940079322 interferon Drugs 0.000 claims 1
- 108090000681 interleukin 20 Proteins 0.000 claims 1
- 108010074108 interleukin-21 Proteins 0.000 claims 1
- 108010074109 interleukin-22 Proteins 0.000 claims 1
- 108090000237 interleukin-24 Proteins 0.000 claims 1
- 210000002510 keratinocyte Anatomy 0.000 claims 1
- 239000002523 lectin Substances 0.000 claims 1
- 229940039781 leptin Drugs 0.000 claims 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims 1
- 229940040129 luteinizing hormone Drugs 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 229960003646 lysine Drugs 0.000 claims 1
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 claims 1
- 230000009826 neoplastic cell growth Effects 0.000 claims 1
- 229940032018 neurotrophin 3 Drugs 0.000 claims 1
- 229940097998 neurotrophin 4 Drugs 0.000 claims 1
- 229940097325 prolactin Drugs 0.000 claims 1
- 229940092597 prolia Drugs 0.000 claims 1
- 229960000856 protein c Drugs 0.000 claims 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims 1
- 125000005629 sialic acid group Chemical group 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 210000000115 thoracic cavity Anatomy 0.000 claims 1
- 229960000187 tissue plasminogen activator Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261647814P | 2012-05-16 | 2012-05-16 | |
| US61/647,814 | 2012-05-16 | ||
| US13/488,043 | 2012-06-04 | ||
| US13/488,043 US8809501B2 (en) | 2009-07-27 | 2012-06-04 | Nucleophilic catalysts for oxime linkage |
| JP2020067396A JP7014844B2 (ja) | 2012-05-16 | 2020-04-03 | オキシム連結のための求核触媒 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020067396A Division JP7014844B2 (ja) | 2012-05-16 | 2020-04-03 | オキシム連結のための求核触媒 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022034075A JP2022034075A (ja) | 2022-03-02 |
| JP2022034075A5 true JP2022034075A5 (enExample) | 2022-03-16 |
| JP7304402B2 JP7304402B2 (ja) | 2023-07-06 |
Family
ID=48579473
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015512831A Active JP6195611B2 (ja) | 2012-05-16 | 2013-05-16 | オキシム連結のための求核触媒 |
| JP2017109323A Active JP6560712B2 (ja) | 2012-05-16 | 2017-06-01 | オキシム連結のための求核触媒 |
| JP2019018663A Active JP6711935B2 (ja) | 2012-05-16 | 2019-02-05 | オキシム連結のための求核触媒 |
| JP2020067396A Active JP7014844B2 (ja) | 2012-05-16 | 2020-04-03 | オキシム連結のための求核触媒 |
| JP2021215385A Active JP7304402B2 (ja) | 2012-05-16 | 2021-12-29 | オキシム連結のための求核触媒 |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015512831A Active JP6195611B2 (ja) | 2012-05-16 | 2013-05-16 | オキシム連結のための求核触媒 |
| JP2017109323A Active JP6560712B2 (ja) | 2012-05-16 | 2017-06-01 | オキシム連結のための求核触媒 |
| JP2019018663A Active JP6711935B2 (ja) | 2012-05-16 | 2019-02-05 | オキシム連結のための求核触媒 |
| JP2020067396A Active JP7014844B2 (ja) | 2012-05-16 | 2020-04-03 | オキシム連結のための求核触媒 |
Country Status (12)
| Country | Link |
|---|---|
| EP (3) | EP2849795B1 (enExample) |
| JP (5) | JP6195611B2 (enExample) |
| KR (4) | KR102237306B1 (enExample) |
| CN (2) | CN109620963B (enExample) |
| AU (1) | AU2013204754C1 (enExample) |
| BR (1) | BR112014028636B1 (enExample) |
| CA (1) | CA2873756C (enExample) |
| EA (2) | EA035506B1 (enExample) |
| MX (1) | MX360594B (enExample) |
| NZ (4) | NZ701945A (enExample) |
| SG (3) | SG10201911328QA (enExample) |
| WO (2) | WO2013173557A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013204754C1 (en) * | 2012-05-16 | 2018-10-11 | Takeda Pharmaceutical Company Limited | Nucleophilic Catalysts for Oxime Linkage |
| IL266361B2 (en) * | 2016-11-14 | 2024-02-01 | Novartis Ag | Methods and preparations for the treatment of cartilage damage and arthritis |
| JP7002036B2 (ja) * | 2016-11-17 | 2022-01-20 | パナソニックＩｐマネジメント株式会社 | 膜電極接合体および固体酸化物形燃料電池 |
| US11786586B2 (en) | 2016-12-23 | 2023-10-17 | Aoa Dx | Carbohydrate structures and uses thereof |
| CN108503901B (zh) * | 2018-04-17 | 2020-07-07 | 哈尔滨工业大学 | 一种抗菌普鲁兰多糖/壳聚糖复合食品包装膜的制备方法 |
| SG11202107497XA (en) | 2019-01-23 | 2021-08-30 | Regeneron Pharma | Treatment of ophthalmic conditions with angiopoietin-like 7 (angptl7) inhibitors |
| US11845989B2 (en) | 2019-01-23 | 2023-12-19 | Regeneron Pharmaceuticals, Inc. | Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors |
| EP4298219A1 (en) | 2021-02-26 | 2024-01-03 | Regeneron Pharmaceuticals, Inc. | Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (angptl7) inhibitors |
| EP4491603A1 (en) | 2022-03-07 | 2025-01-15 | Kaneka Corporation | Method for producing granular composition containing glutathione |
| WO2025133203A1 (en) * | 2023-12-22 | 2025-06-26 | Pam Theragnostics Gmbh | Compounds and methods for a long-lasting pam |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54113492A (en) | 1978-02-24 | 1979-09-05 | Sanyo Chem Ind Ltd | Preparation of glucoprotein derivative |
| US4356170A (en) | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US5250421A (en) | 1986-01-03 | 1993-10-05 | Genetics Institute, Inc. | Method for producing factor VIII:C-type proteins |
| US5198349A (en) | 1986-01-03 | 1993-03-30 | Genetics Institute, Inc. | Method for producing factor VIII:C and analogs |
| JPH0387173A (ja) | 1987-09-10 | 1991-04-11 | Teijin Ltd | ヒト活性化天然型ファクター８ｃの製造方法及びそれに用いる形質転換体 |
| US5846951A (en) | 1991-06-06 | 1998-12-08 | The School Of Pharmacy, University Of London | Pharmaceutical compositions |
| NZ256921A (en) | 1992-10-02 | 1996-05-28 | Pharmacia Ab | Formulations of coagulation factor viii and a non-ionic surfactant and their preparation |
| NZ250375A (en) * | 1992-12-09 | 1995-07-26 | Ortho Pharma Corp | Peg hydrazone and peg oxime linkage forming reagents and protein derivatives |
| WO1994028024A1 (en) * | 1993-06-01 | 1994-12-08 | Enzon, Inc. | Carbohydrate-modified polymer conjugates with erythropoietic activity |
| US5621039A (en) | 1993-06-08 | 1997-04-15 | Hallahan; Terrence W. | Factor IX- polymeric conjugates |
| WO1996040662A2 (en) | 1995-06-07 | 1996-12-19 | Cellpro, Incorporated | Aminooxy-containing linker compounds and their application in conjugates |
| WO1999003496A1 (en) | 1997-07-21 | 1999-01-28 | The University Of North Carolina At Chapel Hill | Factor ix antihemophilic factor with increased clotting activity |
| US7074878B1 (en) | 1999-12-10 | 2006-07-11 | Harris J Milton | Hydrolytically degradable polymers and hydrogels made therefrom |
| US6413507B1 (en) | 1999-12-23 | 2002-07-02 | Shearwater Corporation | Hydrolytically degradable carbamate derivatives of poly (ethylene glycol) |
| ES2256234T3 (es) | 2000-05-16 | 2006-07-16 | Lipoxen Technologies Limited | Derivatizacion de proteinas en solucion acuosa. |
| US7265084B2 (en) | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| KR100948532B1 (ko) | 2001-11-07 | 2010-03-23 | 넥타르 테라퓨틱스 | 분지형 중합체 및 그의 공액체 |
| CA2496317C (en) | 2002-09-11 | 2014-02-18 | Fresenius Kabi Deutschland Gmbh | Method of producing hydroxyalkyl starch derivatives |
| EP1681303B1 (en) | 2002-09-11 | 2013-09-04 | Fresenius Kabi Deutschland GmbH | HASylated polypeptides, especially HASylated erythropoietin |
| ES2512499T3 (es) | 2003-04-08 | 2014-10-24 | Yeda Research And Development Co., Ltd. | Fármacos pegilados reversibles |
| US20070026485A1 (en) | 2003-04-09 | 2007-02-01 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| US20080206182A1 (en) * | 2003-08-08 | 2008-08-28 | Fresenius Kabi Deutschland Gmbh | Conjugates of a Polymer and a Protein Linked by an Oxime Group |
| EP1654290B1 (en) | 2003-08-12 | 2019-03-13 | Lipoxen Technologies Limited | Sialic acid derivatives for protein derivatisation and conjugation |
| US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
| US20060040856A1 (en) | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
| NZ547554A (en) | 2003-12-03 | 2009-09-25 | Biogenerix Ag | Glycopegylated granulocyte colony stimulating factor |
| ES2593318T3 (es) | 2004-08-12 | 2016-12-07 | Lipoxen Technologies Limited | Derivados de ácido siálico |
| US8268967B2 (en) | 2004-09-10 | 2012-09-18 | Novo Nordisk A/S | Glycopegylated interferon α |
| DK1835938T3 (da) | 2004-12-27 | 2013-11-04 | Baxter Int | Polymer-von Willebrand-faktor-konjugater |
| CN101242858B (zh) | 2005-06-16 | 2012-12-19 | 尼克塔治疗公司 | 具有可降解键的轭合物以及用于制备这种轭合物的聚合物试剂 |
| US7645860B2 (en) | 2006-03-31 | 2010-01-12 | Baxter Healthcare S.A. | Factor VIII polymer conjugates |
| EP2059527B1 (en) | 2006-09-01 | 2014-12-03 | Novo Nordisk Health Care AG | Modified glycoproteins |
| BRPI0720282B8 (pt) | 2006-12-15 | 2021-05-25 | Baxalta GmbH | construção proteica, composição farmacêutica, e, kit |
| GB0908393D0 (en) * | 2009-05-15 | 2009-06-24 | Almac Sciences Scotland Ltd | Labelling method |
| AU2010281453C1 (en) * | 2009-07-27 | 2019-08-15 | Takeda Pharmaceutical Company Limited | Blood coagulation protein conjugates |
| EP3081233B1 (en) * | 2009-07-27 | 2020-12-23 | Baxalta GmbH | Glycopolysialylation of proteins other than blood coagulation proteins |
| DK2598172T3 (da) * | 2010-07-30 | 2019-07-01 | Baxalta GmbH | Nukleofile katalysatorer til oximforbindelse |
| KR101560541B1 (ko) * | 2012-04-13 | 2015-10-19 | 아우토리브 디벨롭먼트 아베 | 에어백 모듈과 스티어링 휠의 조립체 |
| AU2013204754C1 (en) * | 2012-05-16 | 2018-10-11 | Takeda Pharmaceutical Company Limited | Nucleophilic Catalysts for Oxime Linkage |
-
2013
- 2013-04-12 AU AU2013204754A patent/AU2013204754C1/en active Active
- 2013-05-16 MX MX2014013919A patent/MX360594B/es active IP Right Grant
- 2013-05-16 EA EA201790935A patent/EA035506B1/ru not_active IP Right Cessation
- 2013-05-16 EA EA201492115A patent/EA028186B9/ru not_active IP Right Cessation
- 2013-05-16 NZ NZ701945A patent/NZ701945A/en unknown
- 2013-05-16 NZ NZ738844A patent/NZ738844A/en unknown
- 2013-05-16 KR KR1020207013096A patent/KR102237306B1/ko active Active
- 2013-05-16 CN CN201811295900.8A patent/CN109620963B/zh active Active
- 2013-05-16 EP EP13728026.9A patent/EP2849795B1/en active Active
- 2013-05-16 KR KR1020217009701A patent/KR102287040B1/ko active Active
- 2013-05-16 CA CA2873756A patent/CA2873756C/en active Active
- 2013-05-16 BR BR112014028636-1A patent/BR112014028636B1/pt active IP Right Grant
- 2013-05-16 NZ NZ724828A patent/NZ724828A/en unknown
- 2013-05-16 WO PCT/US2013/041300 patent/WO2013173557A1/en not_active Ceased
- 2013-05-16 SG SG10201911328QA patent/SG10201911328QA/en unknown
- 2013-05-16 SG SG10201701780RA patent/SG10201701780RA/en unknown
- 2013-05-16 KR KR1020217024432A patent/KR102326360B1/ko active Active
- 2013-05-16 EP EP21214357.2A patent/EP4019049A1/en active Pending
- 2013-05-16 NZ NZ738846A patent/NZ738846A/en unknown
- 2013-05-16 SG SG11201407597XA patent/SG11201407597XA/en unknown
- 2013-05-16 EP EP13724491.9A patent/EP2849794A1/en not_active Withdrawn
- 2013-05-16 KR KR1020147035113A patent/KR102110622B1/ko active Active
- 2013-05-16 WO PCT/US2013/041280 patent/WO2013173543A1/en not_active Ceased
- 2013-05-16 JP JP2015512831A patent/JP6195611B2/ja active Active
- 2013-05-16 CN CN201380037823.5A patent/CN104487095B/zh active Active
-
2017
- 2017-06-01 JP JP2017109323A patent/JP6560712B2/ja active Active
-
2019
- 2019-02-05 JP JP2019018663A patent/JP6711935B2/ja active Active
-
2020
- 2020-04-03 JP JP2020067396A patent/JP7014844B2/ja active Active
-
2021
- 2021-12-29 JP JP2021215385A patent/JP7304402B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022034075A5 (enExample) | ||
| JP2022046676A5 (enExample) | ||
| JP2020111599A5 (enExample) | ||
| JP2015520163A5 (enExample) | ||
| JP2019089810A5 (enExample) | ||
| JP2019116500A5 (enExample) | ||
| US7105160B1 (en) | Antibody-serum protein hybrids | |
| Kreitman et al. | Purification and characterization of IL6-PE4E, a recombinant fusion of interleukin 6 with Pseudomonas exotoxin | |
| Buchner et al. | A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies | |
| HRP20190990T1 (hr) | Nukleofilni katalisti za vezanje oksima | |
| JP3497175B2 (ja) | 一価の（ｍｏｎｏｖａｌｅｎｔ）抗体フラグメント | |
| Doherty et al. | Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor | |
| Kontos et al. | Drug development: longer-lived proteins | |
| EP1912673B1 (en) | Process for attaching effector molecules to proteins | |
| JP6240122B2 (ja) | 官能基化試薬およびその使用 | |
| RU2002106234A (ru) | Комплексы антител с несколькими цитокинами | |
| WO2017143839A1 (zh) | 基于内含肽的药用重组蛋白的合成方法 | |
| CN109620963A (zh) | 用于肟键联的亲核性催化剂 | |
| JP5349501B2 (ja) | セレン含有改質剤及びコンジュゲート（Ｃｏｎｊｕｇａｔｅｓ） | |
| JPH03501622A (ja) | 蛋白誘導体及びその調製法 | |
| CN107108691B (zh) | 蛋白质制造方法 | |
| CN100391979C (zh) | 一种单甲氧基聚乙二醇-胰岛素复合物及其制备方法 | |
| JP2009514814A (ja) | グリコール化およびグリコシル化された家禽類由来の治療用たんぱく質 | |
| WO1992014832A1 (fr) | Procedes pour la purification de fdlb humains | |
| CN1228476A (zh) | 人粒细胞巨噬细胞集落刺激因子制备方法及其表达载体和工程菌 |